Crossmark

Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer

Published Online: 2026-03-28

Published Print: 2026-05

Authors

Chiddarwar, Tanvi https://orcid.org/0009-0000-2865-9147
Blaes, Anne

Kuntz, Karen
License Information

Text and Data Mining valid from 2026-03-28

Version of Record valid from 2026-03-28
More Information

Article History

Received: 30 October 2025

Accepted: 14 March 2026

First Online: 28 March 2026

Declarations

:

: The authors declare no competing interests.

Document is current